Small Molecule Microarrays for Drug Discovery

แชร์
ฝัง
  • เผยแพร่เมื่อ 1 ก.ค. 2024
  • The speaker is Dr. Adam Buckle, Chief Scientific Officer at Arrayjet, hosted by Oleksii Gavrylenko, Chemspace Chief Operating Officer.
    We discussed the following topics related to the Small Molecule Microarray (SMM) methodology:
    - What a SMM is, how they were developed, and how they are used;
    - The full process of how SMM screening is carried out;
    - The types of target molecules SMM can be used for, including case studies;
    - How the technique addresses current drug discovery challenges.
    For more details please visit our website (tinyurl.com/24tjzubu) or drop us a line: sales@chem-space.com!
    #Chemspace #Arrayjet
    ____________________________________________________________________________________
    If you would like to keep up on the latest news and updates, follow us on social media:
    LinkedIn: / chemspace
    Twitter: / chem_space
    Instagram: / _chemspace_
    Facebook: / chemspace
    0:00 Start of the webinar
    2:40 Chemspace introduction by Oleksii Gavrylenko, Chief Operating Officer
    9:52 Speaker introduction - Dr. Adam Buckle, CSO at Arrayjet
    11:42 Introduction to Small Molecule Microarraying
    11:58 Overview of the presentation
    12:23 Arrayjet’s focus
    12:59 Arrayjet products and services
    13:51 What is a microarray?
    14:43 What is a small molecule microarray?
    15:30 Process overview: small molecule microarray.
    16:05 Part 1. Small molecule libraries
    18:08 Part 2. Isocyanate surface chemistry
    20:00 Surface reactivity test for SM binding
    22:26 Isocyanate surface chemistry: Why is it important?
    23:33 Part 3. Printing: Mercury for Small Molecule Screening
    24:16 Mercury only uses inkjet
    24:53 Microfluidic sample transfer
    25:40 A simplified view: aspiration and printing
    26:24 We image every printed spot
    26:51 Why Arrayjet and Small Molecule Microarraying (SMM)
    28:58 Part 4. Binding assay and hits identification
    29:11 Target types for screening assay - Protein and RNA
    32:34 Protein SMM: Rapamycin example
    34:02 Targeted protein degradation. PROTACs
    37:03 Drugging RNA
    38:58 Riboswitches as a Paradigm for understanding structural RNA
    40:20 PreQ1-riboswitch SMM case study
    42:04 Example SMM assay: PreQ1-riboswitch
    43:26 Example SMM screen
    44:30 Part 5. Validation. Target validation using SPR imaging
    48:07 Benefits of SMM
    50:34 Summary of SMM
    50:42 Q&A session
  • วิทยาศาสตร์และเทคโนโลยี

ความคิดเห็น •